Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$896M Sell
9,876,345
-1,315,508
-12% -$120M 0.21% 86
2026
Q1
$1.15B Sell
11,191,853
-602,952
-5% -$68.1M 0.31% 62
2025
Q4
$1.48B Buy
11,794,805
+140,244
+1% +$17.9M 0.39% 44
2025
Q3
$1.56B Sell
11,654,561
-566,386
-5% -$74.4M 0.41% 36
2025
Q2
$1.66B Sell
12,220,947
-279,464
-2% -$36.9M 0.46% 30
2025
Q1
$1.66B Buy
12,500,411
+1,441,687
+13% +$183M 0.5% 33
2024
Q4
$1.25B Sell
11,058,724
-38,382
-0.3% -$4.44M 0.35% 45
2024
Q3
$1.27B Buy
11,097,106
+251,582
+2% +$27.6M 0.36% 49
2024
Q2
$1.13B Sell
10,845,524
-46,670
-0.4% -$4.95M 0.33% 53
2024
Q1
$1.24B Sell
10,892,194
-1,473,948
-12% -$169M 0.37% 49
2023
Q4
$1.36B Buy
12,366,142
+286,258
+2% +$28.6M 0.44% 40
2023
Q3
$1.17B Sell
12,079,884
-504,217
-4% -$53M 0.41% 48
2023
Q2
$1.37B Buy
12,584,101
+516,810
+4% +$55.1M 0.48% 36
2023
Q1
$1.22B Buy
12,067,291
+492,031
+4% +$52M 0.45% 40
2022
Q4
$1.27B Buy
11,575,260
+614,693
+6% +$63.6M 0.49% 43
2022
Q3
$1.06B Sell
10,960,567
-274,367
-2% -$29.2M 0.43% 48
2022
Q2
$1.22B Buy
11,234,934
+914,709
+9% +$104M 0.47% 39
2022
Q1
$1.26B Sell
10,320,225
-1,149,088
-10% -$142M 0.41% 46
2021
Q4
$1.61B Buy
11,469,313
+1,609,489
+16% +$206M 0.48% 39
2021
Q3
$1.16B Buy
9,859,824
+1,304,306
+15% +$160M 0.36% 47
2021
Q2
$992M Sell
8,555,518
-272,703
-3% -$31.8M 0.3% 68
2021
Q1
$1.06B Sell
8,828,221
-546,646
-6% -$64.8M 0.34% 56
2020
Q4
$1.03B Buy
9,374,867
+4,198
+0% +$456K 0.35% 56
2020
Q3
$1.02B Sell
9,370,669
-729,924
-7% -$74.1M 0.39% 52
2020
Q2
$923M Buy
10,100,593
+403,277
+4% +$36.4M 0.38% 57
2020
Q1
$765M Sell
9,697,316
-1,280,522
-12% -$107M 0.37% 56
2019
Q4
$954M Sell
10,977,838
-769,059
-7% -$64.4M 0.36% 57
2019
Q3
$983M Sell
11,746,897
-631,047
-5% -$53.6M 0.4% 47
2019
Q2
$1.04B Buy
12,377,944
+12,222,999
+7,889% +$962M 0.41% 43
2019
Q1
$12.4M Sell
154,945
-1,488
-1% -$111K 0.07% 375
2018
Q4
$11.3M Sell
156,433
-1,692
-1% -$119K 0.07% 376
2018
Q3
$11.6M Buy
158,125
+6,245
+4% +$410K 0.06% 407
2018
Q2
$9.26M Buy
151,880
+34,545
+29% +$2.09M 0.06% 405
2018
Q1
$7.03M Sell
117,335
-180
-0.2% -$10.8K 0.05% 435
2017
Q4
$6.71M Sell
117,515
-702
-0.6% -$38.9K 0.04% 444
2017
Q3
$6.31M Sell
118,217
-1,771
-1% -$88.9K 0.04% 456
2017
Q2
$5.83M Sell
119,988
-48,543
-29% -$2.2M 0.04% 490
2017
Q1
$7.48M Sell
168,531
-180,720
-52% -$7.81M 0.04% 469
2016
Q4
$13.4M Buy
349,251
+156,125
+81% +$6.19M 0.07% 363
2016
Q3
$8.17M Buy
193,126
+235
+0.1% +$10.1K 0.05% 435
2016
Q2
$7.58M Sell
192,891
-2,602
-1% -$104K 0.05% 417
2016
Q1
$8.18K Sell
195,493
-473,680
-71% -$18.8M 0.04% 377
2015
Q4
$30.1K Buy
669,173
+503,277
+303% +$22.2M 0.15% 141
2015
Q3
$6.67K Sell
165,896
-21,951
-12% -$1.03M 0.04% 415
2015
Q2
$9.22K Sell
187,847
-1,117
-0.6% -$53.6K 0.05% 401
2015
Q1
$8.76M Buy
188,964
+694
+0.4% +$31.9K 0.05% 414
2014
Q4
$8.48M Buy
188,270
+62,396
+50% +$2.72M 0.05% 426
2014
Q3
$5.24M Sell
125,874
-1,272
-1% -$53.8K 0.03% 536
2014
Q2
$5.2M Sell
127,146
-14,237
-10% -$559K 0.03% 544
2014
Q1
$5.45M Sell
141,383
-5,262
-4% -$203K 0.03% 510
2013
Q4
$5.62M Sell
146,645
-194,452
-57% -$7.17M 0.04% 492
2013
Q3
$11.3M Sell
341,097
-4,865
-1% -$171K 0.07% 326
2013
Q2
$12.1M Buy
+345,962
New +$12.7M 0.08% 309

Other funds holding ABT

Nuveen's ABT Position: Q2 2026 in Review

Nuveen reduced its Abbott (ABT) stake by 12% in Q2 2026, selling an estimated $120M and leaving 9,876,345 shares worth $896M. The position accounts for 0.21% of the portfolio, ranked #86.

Nuveen first reported a position in ABT in Q2 2013 and has held it in 53 quarters since. The position peaked at $1.66B in Q2 2025. 2,950 funds tracked by Wall St. Rank hold ABT as of Q2 2026.

  • Nuveen held 9,876,345 shares of Abbott worth $896M as of Q2 2026.
  • Nuveen sold 1,315,508 Abbott shares in Q2 2026, an estimated $120M.
  • Abbott made up 0.21% of Nuveen's portfolio in Q2 2026, its #86 holding.
  • Nuveen first reported a position in Abbott in Q2 2013 and has held it in 53 quarters since.
  • Nuveen's Abbott position peaked at $1.66B in Q2 2025.
  • 2,950 funds tracked by Wall St. Rank held Abbott as of Q2 2026.

Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.